UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000042908 |
|---|---|
| Receipt number | R000048982 |
| Scientific Title | Exploration of predictive biomarkers in checkpoint inhibitor, nivolumab, for recurrent esophageal squamous cell carcinoma after standard therapy |
| Date of disclosure of the study information | 2021/01/05 |
| Last modified on | 2023/01/10 08:08:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/01/05 14:37:10 | ||
| 2 | Update | 2022/07/07 10:01:06 | Recruitment status Anticipated trial start date Last follow-up date |
|
| 3 | Update | 2022/07/07 10:06:28 | Date of IRB Date trial data considered complete Date analysis concluded |
|
| 4 | Update | 2022/07/07 10:11:38 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2022/07/07 10:12:57 | Number of participants that the trial has enrolled |
|
| 6 | Update | 2023/01/10 08:08:05 | Recruitment status |
